Drug
S47445
S47445: highest development phase Phase 2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| S47445 5mg NCT02626572 | Phase 2 | Alzheimer's Disease |
Latest
No recent events.
Follow S47445 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.